Stay updated on JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Sign up to get notified when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.

Latest updates to the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRecruitment status now shows the study is not enrolling participants. The page also received minor navigation and formatting adjustments, including new help sections and a standardization of the Intervention/Treatment label and revision history.SummaryDifference0.4%

- Check18 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4; this indicates a new page build/version and does not alter the study details or eligibility information.SummaryDifference0.1%

- Check39 days agoChange DetectedThe revision label changes from v3.5.3 to v3.5.4, indicating a platform/template update. This metadata update does not appear to alter the displayed study details or content.SummaryDifference0.1%

- Check61 days agoChange DetectedClinicalTrials.gov’s page footer revision label was updated from v3.5.2 to v3.5.3, indicating a site/version change without altering the study details shown.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision notes updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.1%

- Check97 days agoChange DetectedSite revision updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.